Literature DB >> 15741218

Expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors.

Puneet S Jolly1, Meryem Bektas, Kenneth R Watterson, Heidi Sankala, Shawn G Payne, Sheldon Milstien, Sarah Spiegel.   

Abstract

Mast cells play a central role in inflammatory and immediate-type allergic reactions by secreting a variety of biologically active substances, including sphingosine-1 phosphate (S1P). Sphingosine kinase 1 (SphK1) and formation of S1P, which leads to transactivation of S1P receptors and their downstream signaling pathways, regulates mast-cell functions initiated by cross-linking of the high-affinity immunoglobulin E (IgE) receptor FcepsilonRI. Surprisingly, overexpression of SphK1 in rat basophilic leukemia (RBL)-2H3 mast cells impaired degranulation as well as migration toward antigen. These effects were reversed by serum withdrawal, yet the increased formation and secretion of S1P were the same as in the presence of serum. Nonetheless, serum increased localization of SphK1 at the plasma membrane. This restricted formation of S1P induced internalization and desensitization of S1P receptors on the surface of mast cells as determined by confocal immunofluorescence microscopy, aberrant S1P receptor signaling, and lack of S1P receptor coupling to G proteins. Serum starvation, which significantly reduced membrane-associated SphK1 activity, restored S1P receptor functions. Our results have important implications for mast-cell migration and degranulation as well as for the biologic functions of the S1P receptors on cells that are circulating in the bloodstream.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15741218      PMCID: PMC1894993          DOI: 10.1182/blood-2004-12-4686

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

Review 2.  Biologically active sphingolipids in cancer pathogenesis and treatment.

Authors:  Besim Ogretmen; Yusuf A Hannun
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 3.  Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs.

Authors:  Jason G Cyster
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Sphingosine 1-phosphate and platelet-derived growth factor (PDGF) act via PDGF beta receptor-sphingosine 1-phosphate receptor complexes in airway smooth muscle cells.

Authors:  Catherine Waters; Balwinder Sambi; Kok-Choi Kong; Dawn Thompson; Stuart M Pitson; Susan Pyne; Nigel J Pyne
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

5.  Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors.

Authors:  F Wang; J R Van Brocklyn; L Edsall; V E Nava; S Spiegel
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

6.  Enzymatic measurement of sphingosine 1-phosphate.

Authors:  L C Edsall; S Spiegel
Journal:  Anal Biochem       Date:  1999-07-15       Impact factor: 3.365

7.  Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation. A dominant-negative sphingosine kinase.

Authors:  S M Pitson; P A Moretti; J R Zebol; P Xia; J R Gamble; M A Vadas; R J D'Andrea; B W Wattenberg
Journal:  J Biol Chem       Date:  2000-10-27       Impact factor: 5.157

Review 8.  Pleiotropic actions of sphingosine-1-phosphate.

Authors:  Kenneth Watterson; Heidi Sankala; Sheldon Milstien; Sarah Spiegel
Journal:  Prog Lipid Res       Date:  2003-07       Impact factor: 16.195

Review 9.  Sphingosine 1-phosphate and its type 1 G protein-coupled receptor: trophic support and functional regulation of T lymphocytes.

Authors:  Edward J Goetzl; Markus H Gräler
Journal:  J Leukoc Biol       Date:  2004-02-24       Impact factor: 4.962

10.  Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis.

Authors:  Puneet S Jolly; Meryem Bektas; Ana Olivera; Claudia Gonzalez-Espinosa; Richard L Proia; Juan Rivera; Sheldon Milstien; Sarah Spiegel
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  23 in total

Review 1.  G protein-coupled receptors and the modification of FcepsilonRI-mediated mast cell activation.

Authors:  Hye Sun Kuehn; Alasdair M Gilfillan
Journal:  Immunol Lett       Date:  2007-09-18       Impact factor: 3.685

2.  FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration.

Authors:  In Duk Jung; Hyun-Sil Lee; Hoi Young Lee; Oksoon Hong Choi
Journal:  Cell Signal       Date:  2009-07-24       Impact factor: 4.315

3.  Role of ABCC1 in export of sphingosine-1-phosphate from mast cells.

Authors:  Poulami Mitra; Carole A Oskeritzian; Shawn G Payne; Michael A Beaven; Sheldon Milstien; Sarah Spiegel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-18       Impact factor: 11.205

Review 4.  Sphingolipid signaling and hematopoietic malignancies: to the rheostat and beyond.

Authors:  Kenneth C Loh; Dianna Baldwin; Julie D Saba
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 5.  IgE-dependent signaling as a therapeutic target for allergies.

Authors:  Donald W MacGlashan
Journal:  Trends Pharmacol Sci       Date:  2012-06-30       Impact factor: 14.819

6.  Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking.

Authors:  Maria L Allende; Meryem Bektas; Bridgin G Lee; Eliana Bonifacino; Jiman Kang; Galina Tuymetova; WeiPing Chen; Julie D Saba; Richard L Proia
Journal:  J Biol Chem       Date:  2010-12-20       Impact factor: 5.157

Review 7.  The role of sphingosine-1-phosphate and its receptors in asthma.

Authors:  John J Ryan; Sarah Spiegel
Journal:  Drug News Perspect       Date:  2008-03

8.  Essential roles of sphingosine-1-phosphate receptor 2 in human mast cell activation, anaphylaxis, and pulmonary edema.

Authors:  Carole A Oskeritzian; Megan M Price; Nitai C Hait; Dmitri Kapitonov; Yves T Falanga; Johanna K Morales; John J Ryan; Sheldon Milstien; Sarah Spiegel
Journal:  J Exp Med       Date:  2010-03-01       Impact factor: 14.307

9.  Usage of sphingosine kinase isoforms in mast cells is species and/or cell type determined.

Authors:  Sandra E Dillahunt; Jennifer L Sargent; Ryo Suzuki; Richard L Proia; Alasdair Gilfillan; Juan Rivera; Ana Olivera
Journal:  J Immunol       Date:  2013-01-28       Impact factor: 5.422

10.  High-resolution three-dimensional imaging of the rich membrane structures of bone marrow-derived mast cells.

Authors:  T Zink; Z Deng; H Chen; L Yu; F T Liu; G Y Liu
Journal:  Ultramicroscopy       Date:  2008-08-06       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.